Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
93.05
-1.15 (-1.22%)
At close: Jun 18, 2026, 4:00 PM EDT
92.80
-0.25 (-0.27%)
After-hours: Jun 18, 2026, 7:19 PM EDT
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $1.37 billion as of June 18, 2026. Its market cap has increased by 625.43% in one year.
Market Cap
1.37B
Enterprise Value
1.38B
1-Year Change
625.43%
Ranking
Category
Stock Price
$93.05
Market Cap Chart
Since May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $1.37B, an increase of 588.65%. That is a compound annual growth rate of 155.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.37B | 18.82% |
| Dec 31, 2025 | 1.15B | 415.39% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fortrea Holdings | 1.45B |
| Maze Therapeutics | 1.42B |
| MoonLake Immunotherapeutics | 1.41B |
| Savara | 1.39B |
| Maravai LifeSciences Holdings | 1.34B |
| Immatics | 1.34B |
| Aktis Oncology | 1.33B |
| Avalyn Pharma | 1.31B |